Owlet, Inc.
$5.82
▲
0.2%
2026-04-21 08:43:00
www.owletcare.com
NYQ: OWLT
Explore Owlet, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$163.61 M
Current Price
$5.82
52W High / Low
$16.94 / $3.08
Stock P/E
—
Book Value
$0.71
Dividend Yield
—
ROCE
-19.96%
ROE
-8.02%
Face Value
—
EPS
$-2.31
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
108
Beta
1.98
Debt / Equity
42.26
Current Ratio
1.85
Quick Ratio
1.51
Forward P/E
93.94
Price / Sales
1.33
Enterprise Value
$130.73 M
EV / EBITDA
-16.22
EV / Revenue
1.24
Rating
Strong Buy
Target Price
$14.25
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Boston Scientific Corporation | $65.03 | 33.52 | $96.13 B | 0% | 10.39% | 12.45% | $109.5 / $60.59 | $16.34 |
| 2. | Bruker Corporation | $41.1 | — | $6.23 B | 0.49% | 4.76% | -0.38% | $56.22 / $28.53 | $16.15 |
| 3. | Delcath Systems, Inc. | $10.88 | 139.76 | $377.34 M | — | 0.59% | 3% | $18.23 / $8.12 | $3.21 |
| 4. | Phaos Technology Holdings (Caym | $1.95 | — | — | — | 214.51% | -10.73% | $7.39 / $0.53 | $-0.06 |
| 5. | enVVeno Medical Corporation | $12.08 | — | $7.92 M | — | -76.16% | -56.21% | $196.7 / $8.67 | $41.36 |
| 6. | Integra LifeSciences Holdings Corporation | $11.16 | — | $875.54 M | — | 0.57% | -39.9% | $17.54 / $8.7 | $13.4 |
| 7. | Stryker Corporation | $334.05 | 39.78 | $127.84 B | 1.04% | 12.63% | 15.08% | $404.87 / $319.32 | $58.61 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 26.55 M | 31.99 M | 26.06 M | 21.1 M | 20.48 M | — |
| Operating Profit | -4.89 M | 1.22 M | -1.92 M | -2.67 M | -7.41 M | — |
| Net Profit | -9.19 M | 4.13 M | -37.65 M | 3.02 M | -9.05 M | — |
| EPS in Rs | -0.33 | 0.15 | -1.34 | 0.11 | -0.32 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 105.71 M | 78.06 M | 54.01 M | 69.2 M |
| Operating Profit | -8.26 M | -20.22 M | -28.63 M | -84.62 M |
| Net Profit | -39.68 M | -12.54 M | -32.9 M | -79.34 M |
| EPS in Rs | -1.41 | -0.45 | -1.17 | -2.82 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 85.63 M | 49.52 M | 44.12 M | 58.1 M |
| Total Liabilities | 50.18 M | 66.33 M | 73.8 M | 68.74 M |
| Equity | 35.45 M | -16.81 M | -29.68 M | -10.63 M |
| Current Assets | 81.92 M | 46.11 M | 39.94 M | 51.26 M |
| Current Liabilities | 44.24 M | 36.43 M | 45.09 M | 66.6 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -10.79 M | -11.21 M | -23.53 M | -81.38 M |
| Investing CF | -0.94 M | -0.76 M | -0.06 M | -1.56 M |
| Financing CF | 32.12 M | 16.04 M | 28.91 M | -0.88 M |
| Free CF | -11.73 M | -11.97 M | -23.59 M | -82.94 M |
| Capex | -0.94 M | -0.76 M | -0.06 M | -1.56 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 44.52% | -21.95% | — | — |
| Earnings Growth % | 61.9% | 58.53% | — | — |
| Profit Margin % | -16.06% | -60.92% | -114.64% | — |
| Operating Margin % | -25.9% | -53.01% | -122.28% | — |
| Gross Margin % | 50.36% | 41.82% | 33.69% | — |
| EBITDA Margin % | -12.13% | -50.9% | -109.15% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2023-07-10 | 1:0.0714286 |